NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Genre Guideline Remove constraint Genre: Guideline Genre Technical Report Remove constraint Genre: Technical Report

Search Results

231. M7(R2) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk: guidance for industry

239. Institutional review board (IRB) review of individual patient expanded access submissions for investigational drugs and biological products: guidance for IRBs and clinical investigators

240. Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process": guidance for industry and Food and Drug Administration staff